Scientific publications
The presence of AuraSTOP in scientific publications
The article (Antonaci F., et al.) AuraSTOP in the treatment of migraine aura. International Journal of Neurology and Brain Disorders. 2018.
(Zavarise P., et al. A combination of tanacetum parthenium, Griffonia simplicifolia and magnesium (Aurastop) as symptomatic acutre treatment for migraine aura: a retrospective Cohort Study. Open Access Library Journal 2917;4,E3660
(Zavarise P., et al. Combination of Tanacethum Partenium, 5-Hydroxitriptophan (5-HTTP) and Magnesium in the Prophylaxis of Episodic migraine without aura (Aurastop®) An observational study.
(Ferrare P., et A. Tanacetum, Parthenium, Griffonia simplicifolia and magnesium as symptomatic and prophylactic treatment for headache in Paediatric Patients. International Journal of Neurology and Braind Disorders ISSN 2377-1348).
(Mainardi F., et al. Efficacy of a combination of tanacetum parthenium, 5-hydroxy tryptohan and magnesium (AuraSTOP) in Episodic migraine prevention: a multicentric Observational Study Open Access Library Journal 2018;5,E4765).
(Dal Volta G., et al. Comparison of the effect of Tanacethum parthenium, 5-hydroxy tryptophan, and magnesium (AuraSTOP) versus magnesium alone on aura phenomenon and ITS Evolution. Pain Research and Management. 2019;6320163)
(Dal Volta G., et al. Efficacy of a combination of tanacetum parthenium, 5-hydroxy triptohan and magnesium (AuraSTOP) in the prevention of high frequency migraine with aura. Open Access Library. 2018;5,E4939)